Follow-up: the astounding failure of all three COVID vaccine clinical trials
September 30, 2020
I covered this breaking story last week.
I analyzed a startling piece in the NY Times that torpedoed the major clinical trials now underway, headed up by Pfizer, AstraZeneca, and Moderna.
My readers, who know the devil is in the details, saw how absurd these trials are.
Now I want to go back and fill in a few new facts that round out the picture.
As a result of increased scrutiny and pressure, the vaccine companies couldn’t just say their experimental COVID vaccine produced antibodies, meaning there was a “proper immune response” to the vaccine. That wouldn’t be enough to win FDA approval.
No, they would have to create two huge groups of human volunteers, give one group the vaccine, and the other group a saltwater placebo shot.
Then wait. Since these companies believe the coronavirus is everywhere, descending from the clouds and infecting millions of people, they would wait for some volunteers to “catch COVID-19.”
How many volunteers? 150. That’s the magic number.
At that point, the clinical trial would stop. Everything would stop.
The big reveal would take place. Of these 150 cases of COVID-19, how many occurred in volunteers who got the vaccine, and how many COVID-19 cases occurred in the volunteers who got the placebo saltwater shot?
Get it? In other words, this information would show how successful the vaccine was in protecting the volunteers from COVID-19.
What would the vaccine companies be hoping and praying for? A breakdown like this: only 50 COVID-19 cases in the vaccine group, and 100 cases in the placebo group.
Why? Because this would prove the vaccine was 50% effective in preventing COVID-19. And that percentage is all the FDA requires to issue an authorization for the vaccine—an authorization to shoot up all Americans.
Absurd. Preposterous. 150 volunteers determine whether 350 million Americans will be targeted for a vaccine. But that’s not the bottom line in this story.
Let’s return to the beginning again. The vaccine companies, forced to enroll tens of thousands of live humans in their clinical trials, need to decide: who will these volunteers be?
Will they be the elderly, most of whom are already ill with prior conditions, their immune systems already very weak—who could—as even public health agencies warn—keel over from any vaccine injection? Of course not.
The volunteers will have to be healthy adults. Yes. But that presents a huge and fateful problem.
Remember, these volunteers, after they receive either the vaccine or the placebo, will be sent back to live their lives while everyone waits. Waits to see who “catches COVID-19.”
What sort of COVID-19 illness? Very mild? Quite serious?
The answer is obvious. It can’t be “quite serious.” That would mean pneumonia. The vaccine companies could wait around for 10 years and still not record 150 cases of real pneumonia among these HEALTHY VOLUNTEERS.
No, the vaccine companies would wait for 150 mild cases of COVID-19. Meaning, nothing more than a simple cough, or chills and fever, and a positive PCR test.
(In this article, I won’t describe the MANY problems with the worthless and deceptive PCR test.)
Can you see it yet? The vaccine companies are in a box. They’re trapped.
Their whole clinical trial is DESIGNED to prove the vaccine can protect against MILD CASES of COVID-19. That’s all.
AND NOBODY CARES ABOUT THAT. MILD CASES CURE THEMSELVES. NO VACCINE IS NECESSARY.
A SUCCESSFUL VACCINE SHOULD BE PROTECTING PEOPLE AGAINST THE SERIOUS AND LIFE-THREATENING COVID-19 CASES.
BUT THIS IS NOT WHAT THE CLINICAL TRIALS ARE DESIGNED TO PROVE.
Verdict: the three major ongoing clinical trials of a COVID vaccine are useless. Regardless of outcome, regardless of what kind of vaccine is being tested, the designed protocol for the clinical trials makes the trials irrelevant, useless, and pointless.
Will scientists and doctors and civilians wake up and flood the FDA with objections, and force the agency to reject these clinical trials and these vaccine companies?
Can we spread the truth about these clinical trials far and wide?
“Let’s wait and see what happens” isn’t good enough.
Not by a long shot.